(E)-2-(4-biphenylyl)-4-hexenoic acid | 447465-23-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: (E)-2-(4-biphenylyl)-4-hexenoic acid
• 英文别名: (+/-)-2-biphenyl-4-yl-hex-4t-enoic acid；(+/-)-2-Biphenyl-4-yl-hex-4t-ensaeure；2-(4-biphenylyl)-4-hexenoic acid；2-biphenyl-4-yl-hex-4-enoic acid；Xenyhexenic Acid；(E)-2-(4-phenylphenyl)hex-4-enoic acid
• CAS: 447465-23-8
• 化学式: C₁₈H₁₈O₂
• 分子量: 266.34
• InChiKey: ZVRCODPBROUJIT-NSCUHMNNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  20
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (E)-2-(4-biphenylyl)-4-hexenoic acid 、 quinine 生成 (R)-[(2S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;(E)-2-(4-phenylphenyl)hex-4-enoic acid
  参考文献：
  名称：

  DEL, VECCHIO, A.;SESTINI, G.

  摘要：

  DOI：
• 作为产物：
  描述：

  Ethyl 2-(4-methylphenyl)sulfonyl-2-(4-phenylphenyl)acetate 在 magnesium 、 聚二(乙氧基吡咯烷酮)膦腈 、 mercury dichloride 作用下， 以 四氢呋喃 、 甲醇 为溶剂， 反应 48.0h， 生成 (E)-2-(4-biphenylyl)-4-hexenoic acid
  参考文献：
  名称：

  Synthetic Applications of o- and p-Halobenzyl Sulfones as Zwitterionic Synthons:  Preparation of Ortho-Substituted Cinnamates and Biarylacetic Acids

  摘要：

  The synthetic applications of o-halobenzyl and p-halobenzyl sulfones as precursors of 1,3- and 1,5-zwitterionic synthons, respectively, are described. Their alpha-sulfonyl carbanions, generated by means of the phosphazene base P-2-Et or BuLi or K2CO3 under PTC conditions, reacted with different electrophiles such as alkyl halides, aldehydes, and electrophilic olefins. Palladium-catalyzed cross-coupling processes such as Heck, Suzuki, and Sonogashira reactions can be efficiently performed at the halogen atom. These two sequential functionalization processes are applied to the synthesis of ortho-substituted cinnamates and pharmaceuticals belonging to the family of p-biarylacetic acids such as 4-biphenylacetic acid, namoxyrate, xenyhexenic acid, and bipherylpropionic acid.

  DOI：

  10.1021/jo025620s

文献信息

• NK1 and NK3 antagonists
  申请人：O'Neill T. Brian

  公开号：US20050256164A1

  公开（公告）日：2005-11-17

  The invention is to a compound exhibiting neurokinin inhibitory properties, a pharmaceutical composition comprising same and a method of treatment for neurokinin-mediated conditions.

  这项发明涉及一种具有神经激肽抑制性能的化合物，包括该化合物的药物组合物以及用于神经激肽介导疾病的治疗方法。
• Diagnostic/therapeutic agents
  申请人：Klaveness Jo

  公开号：US20050002865A1

  公开（公告）日：2005-01-06

  Targetable diagnostic and/or therapeutically active agents, e.g. ultrasound contrast agents, comprising a suspension in an aqueous carrier liquid of a reporter comprising gas-containing or gas-generating material, said agent being capable of forming at least two types of binding pairs with a target.

  可定位的诊断和/或治疗活性剂，例如超声对比剂，包括悬浮在水载体液中的报告物，该报告物包含含气体或生成气体的材料，该剂能够与目标形成至少两种结合对。
• Improvement in the process for preparing biaryl compounds via coupling of an arylamine with an arene
  申请人：Nobel Chemicals AB

  公开号：EP0100120A1

  公开（公告）日：1984-02-08

  Improvement in the process for preparing biaryl compounds via coupling of an arylamine with an arene in the presence of a nitrite, an acid and copper metal or a derivative thereof; the improvement is consisting in adding to the reaction mixture a trialkylorthoformate. The process may be used for preparing drugs such as Flurbiprofen and Xenbucin or intermediate compounds particularly useful for preparing Flurbiprofen, Flufenisal, Chlordimorin, Xenbucin, Xenysalate, Xenyhexenic acid and the like.

  改进了在亚硝酸盐、酸和金属铜或其衍生物存在下通过芳胺与炔偶联制备双芳基化合物的工艺；改进之处在于在反应混合物中加入了三烷基甲酸原酯。该工艺可用于制备药物，如氟比洛芬（Flurbiprofen）和昔布新（Xenbucin）或中间化合物，特别是用于制备氟比洛芬（Flurbiprofen）、氟苯尼考（Flufenisal）、氯噻莫林（Chlordimorin）、昔布新（Xenbucin）、昔沙拉特（Xenysalate）、昔己酸（Xenyhexenic acid）等。
• Benzofuran derivatives
  申请人：MERCK FROSST CANADA INC.

  公开号：EP0338782A1

  公开（公告）日：1989-10-25

  Benzofuran derivatives are useful as inhibitors of mammalian leuktoriene biosynthesis. As such, these compounds are useful therapeutic agents for treating allergic conditions, asthma, cardiovascular disorders, inflammation. The compounds are also useful as analgesics and as cytoprotective agents, and for these uses are made into pharmaceutical compositions. The compounds of the invention have the formula wherein: each R1 is independently hydrogen or C1 to C6 alkyl; R2 is hydrogen, C1 to C8 alkyl, -(CH2)n-het-Y, -(CH2)n-Q or - CH- Q, CH3 where Q is R3 is hydroxyl, , OCOCH2CH2COOH, OSO3H, or OPO3H2; each R4 is independently C1 to C6 alkyl; each R5 is independently H, C1 to C6 alkyl, or both R5s join to form a 5- or 6-membered ring with the N to which they are attached; Het is a heterocyclic group selected from pyridine, pyrazine, pyrimidine, oxazole, pyrazole, oxadiazole, tetrazole, quinoline, thiophene, furan, pyrrole, thiazole, thiadiazole, or imidazole; X is 0, S, SO, SO2; Y, Y1, Y2, Y3, Y4 and Z are each independently H, halogen, OH. C1 to C6 alkyl, C2 to C6 alkenyl, C1-6hydroxyalkyl, -COOR1, -COR1, nitro, carboxy (C1-6alkyl), C1 to C6 alkoxy, C1 to C6 alkylthio, -CH2SR1, OCH2CO2R1, and each n is independently 0 to 10; with the provisos that: (a) not all of R1, R2, Y, Y1, Y2, Y3, Y4, and Z are simultaneously H; (b) when up to 2 of R1, R2, Y, Y1, and Z are C1 to C2 alkyl, and the others of R1, R2, Y, Y1, and Z are H, then R3 is not OH; and (c) when n in is O and one of R3, Y, Y1 or Z is OH, then Ri is not H or Ci to C2 alkyl; or are acid-addition salts thereof.

  苯并呋喃衍生物可作为哺乳动物白细胞介素生物合成的抑制剂。因此，这些化合物是治疗过敏症、哮喘、心血管疾病和炎症的有效药物。这些化合物还可用作镇痛剂和细胞保护剂，并可用于制成药物组合物。本发明的化合物具有如下式子 其中 每个 R1 独立地为氢或 C1 至 C6 烷基； R2 是氢、C1 至 C8 烷基、-(CH2)n-het-Y、-(CH2)n-Q 或-CH- Q, CH3 其中 Q 是 R3 是羟基、 OCOCH2CH2COOH、OSO3H 或 OPO3H2；每个 R4 独立地是 C1 至 C6 烷基； 每个 R5 独立地为 H、C1-C6 烷基，或两个 R5 与所连接的 N 连接形成 5 或 6 元环； Het 是杂环基团，选自吡啶、吡嗪、嘧啶、噁唑、吡唑、噁二唑、四唑、喹啉、噻吩、呋喃、吡咯、噻唑、噻二唑或咪唑； X 是 0、S、SO、SO2； Y、Y1、Y2、Y3、Y4 和 Z 各自独立地是 H、卤素、OH C1-C6烷基、C2-C6烯基、C1-6羟基烷基、-COOR1、-COR1、硝基、羧基（C1-6烷基）、C1-C6烷氧基、C1-C6烷硫基、-CH2SR1、OCH2CO2R1、 且每个 n 独立地为 0 至 10；但有以下条件： (a) 并非所有 R1、R2、Y、Y1、Y2、Y3、Y4 和 Z 同时都是 H； (b) 当 R1、R2、Y、Y1 和 Z 中最多有 2 个是 C1 至 C2 烷基，而 R1、R2、Y、Y1 和 Z 中的其它是 H 时，则 R3 不是 OH；以及 (c) 当 n 为 O 且 R3、Y、Y1 或 Z 中的一个为 OH 时，则 Ri 不是 H 或 Ci 至 C2 烷基；或为其酸加成盐。
• Products for preventing penetration into the skin
  申请人：——

  公开号：US20040208904A1

  公开（公告）日：2004-10-21

  The present invention relates to novel cosmetic and/or dermatological compounds and compositions for the photoprotection of human skin and/or hair against the damaging effects of UV radiation, in particular solar radiation. In another embodiment the invention relates to compositions and compounds for topical application comprising at least one photoprotective compound for topical application comprising of hydroxylated derivatives of natural Jojoba wax/oil or its synthetic substitute, esterified with carboxylic acids or aminoacids bearing UV-absorbing groups.

  本发明涉及新型化妆品和/或皮肤科化合物及组合物，用于保护人类皮肤和/或头发免受紫外线辐射，特别是太阳辐射的损害。在另一个实施方案中，本发明涉及用于局部应用的组合物和化合物，其中包含至少一种用于局部应用的光保护化合物，该化合物由天然荷荷巴蜡/油的羟基化衍生物或其合成替代物组成，与带有紫外线吸收基团的羧酸或氨基酸酯化。